MRS For Brain Tumors To Retain National Non-Coverage Status, CMS Rules
This article was originally published in The Gray Sheet
Executive Summary
A dearth of studies on the diagnostic performance and patient management of magnetic resonance spectro-scopy for brain tumors played a key role in CMS' decision to maintain its national non-coverage policy